Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
49.4M
-
Shares change
-
+10.6M
-
Total reported value, excl. options
-
$426M
-
Value change
-
+$92.7M
-
Put/Call ratio
-
0
-
Number of buys
-
67
-
Number of sells
-
-27
-
Price
-
$8.62
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q4 2018
116 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q4 2018.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.4M shares
of 374M outstanding shares and own 13.2% of the company stock.
Largest 10 shareholders include LEVIN CAPITAL STRATEGIES, L.P. (9.57M shares), PRIMECAP MANAGEMENT CO/CA/ (6.67M shares), Neuberger Berman Group LLC (5.46M shares), Russell Investments Group, Ltd. (5.16M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.31M shares), BlackRock Inc. (2.14M shares), Vanguard Group Inc (1.8M shares), RENAISSANCE TECHNOLOGIES LLC (1.24M shares), Schonfeld Strategic Advisors LLC (956K shares), and MILLENNIUM MANAGEMENT LLC (933K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.